Concepedia

Jonathan C. O’Connell

JC

Statistics

Publications

20

Citations

898

H-Index

16

Active since

1996

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Forma Therapeutics (United States)

Yale University

DiscoveRx (United States)

Jonathan C. O’Connell is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

1996–2021

20

Publications

20

Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor

Neil T. Burford, Mary J. Clark, Tom S. Wehrman et al. · Proceedings of the National Academy of Sciences · 2013 · 153 citations · Full text

, , +17

The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5)

Jonathan C. O’Connell, J. Fraser McCALLUM, Ian McPhee et al. · Biochemical Journal · 1996 · 99 citations · Full text

, , +17

Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1)

Ashok V. Purandare, Zhong Chen, Tram Huynh et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 90 citations · Full text

, , +9

Discovery, Synthesis, and Molecular Pharmacology of Selective Positive Allosteric Modulators of the δ-Opioid Receptor

Neil T. Burford, Kathryn E. Livingston, Meritxell Canals et al. · Journal of Medicinal Chemistry · 2015 · 73 citations · Full text

, , +17

The unique N‐terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains

Matthew Beard, Jonathan C. O’Connell, Graeme B. Bolger et al. · FEBS Letters · 1999 · 67 citations

, , +17

1–5 of 20